Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0T8VY
|
|||
Former ID |
DIB002302
|
|||
Drug Name |
Aceclofenac
|
|||
Synonyms |
Airtal; Barracan; Biofenac; Bristaflam; Falcol; Gerbin; Preservex; YT-919
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Inflammation [ICD-11: 1A00-CA43.1] | Approved | [1], [2] | |
Company |
Almirall Prodesfarma SA
|
|||
Structure |
Download2D MOL |
|||
Formula |
C16H13Cl2NO4
|
|||
Canonical SMILES |
C1=CC=C(C(=C1)CC(=O)OCC(=O)O)NC2=C(C=CC=C2Cl)Cl
|
|||
InChI |
1S/C16H13Cl2NO4/c17-11-5-3-6-12(18)16(11)19-13-7-2-1-4-10(13)8-15(22)23-9-14(20)21/h1-7,19H,8-9H2,(H,20,21)
|
|||
InChIKey |
MNIPYSSQXLZQLJ-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 89796-99-6
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:31159
|
|||
ADReCS Drug ID | BADD_D00021 |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Prostaglandin G/H synthase (COX) | Target Info | Modulator | [1], [3] |
References | Top | |||
---|---|---|---|---|
REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
REF 2 | ClinicalTrials.gov (NCT01912066) A Multicenter, Double Blinded, Randomized, Parallel Assignment Study to Demonstrate the Efficacy of DA9601. U.S. National Institutes of Health. | |||
REF 3 | Aceclofenac spares cyclooxygenase 1 as a result of limited but sustained biotransformation to diclofenac. Clin Pharmacol Ther. 2003 Sep;74(3):222-35. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.